Literature DB >> 3305024

Localization of viral-specific 21 kDa protein in nucleoli of herpes simplex infected cells.

F Puvion-Dutilleul.   

Abstract

Viral-encoded 21 kDa protein has been localized in herpes simplex virus type 1 (HSV-1) infected cells by immunocytochemical techniques using peroxidase and colloidal gold as markers. During early infection, 21 kDa protein was shown to be in cytoplasmic areas rich in ribosomes located near the nucleus and in the viral DNA-containing fibrillo-granular material of the virus-specific electron-translucent region in the nucleus. Late in infection, an additional marked accumulation occurred in both fibrillar and granular components of the nucleolus. Host chromatin and the nuclear dense bodies remained unlabeled. No immunolabeling was obtained in the absence of DNA replication. In contrast, inhibition of RNA synthesis did not modify the distribution of the protein. On the other hand, persistence of cytoplasmic and nuclear immunolabeling following the inhibition of protein synthesis performed late in infection indicated that the distribution of 21 kDa protein represented, at least in part, sites of accumulation and retention of preexisting molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305024

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  11 in total

1.  Unique motif for nucleolar retention and nuclear export regulated by phosphorylation.

Authors:  Frédéric Catez; Monique Erard; Nathalie Schaerer-Uthurralt; Karine Kindbeiter; Jean-Jacques Madjar; Jean-Jacques Diaz
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Nucleoplasmic and nucleolar distribution of the adenovirus IVa2 gene product.

Authors:  P Lutz; F Puvion-Dutilleul; Y Lutz; C Kedinger
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter.

Authors:  P Lutz; C Kedinger
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  In situ hybridization and immuno-electron microscope analyses of the Us11 gene of herpes simplex virus type 1 during transient expression.

Authors:  S Besse; J J Diaz; E Pichard; K Kindbeiter; J J Madjar; F Puvion-Dutilleul
Journal:  Chromosoma       Date:  1996-03       Impact factor: 4.316

5.  The herpes simplex virus 1 UL11 proteins are associated with cytoplasmic and nuclear membranes and with nuclear bodies of infected cells.

Authors:  J D Baines; R J Jacob; L Simmerman; B Roizman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Identification of transcription factories in nuclei of HeLa cells transiently expressing the Us11 gene of herpes simplex virus type 1.

Authors:  F Puvion-Dutilleul; S Besse; J J Diaz; K Kindbeiter; M Vigneron; S L Warren; C Kedinger; J J Madjar; E Puvion
Journal:  Gene Expr       Date:  1997

7.  Structure and function in the herpes simplex virus 1 RNA-binding protein U(s)11: mapping of the domain required for ribosomal and nucleolar association and RNA binding in vitro.

Authors:  R J Roller; L L Monk; D Stuart; B Roizman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking.

Authors:  Anna Greco; Loredana Arata; Eric Soler; Xavier Gaume; Yohann Couté; Sabine Hacot; Aleth Callé; Karine Monier; Alberto L Epstein; Jean-Charles Sanchez; Philippe Bouvet; Jean-Jacques Diaz
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

9.  The herpes simplex virus type 1 US11 protein binds the coterminal UL12, UL13, and UL14 RNAs and regulates UL13 expression in vivo.

Authors:  Helen L Attrill; Sarah A Cumming; J Barklie Clements; Sheila V Graham
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  A herpes simplex virus 1 US11-expressing cell line is resistant to herpes simplex virus infection at a step in viral entry mediated by glycoprotein D.

Authors:  R J Roller; B Roizman
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.